Anti-VEGF agents have proven to be potent therapeutic agents in ophthalmology for the treatment of Age-related Macular Degeneration (AMD), diabetic macular edema and neovascular glaucoma [47,48,52-54]. This evidence concerns the gene VEGFA and age-related macular degeneration.